Actualités Entasis Therapeutics Holdings Inc - ETTX | Actions NASDAQ | ADVFN

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Entasis Therapeutics Holdings Inc (ETTX)
Entasis Therapeutics Holdings Inc (ETTX) Actualités

Entasis Therapeutics Holdings Inc (ETTX)

2,19

0,00

(0,00%)

Fermé 17 Février 10:00PM

Retardé de 15 minutes

0,00

0,00

(0,00%)

Après les heures de négociation: -

Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022

WALTHAM, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc., a late-stage clinical...

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF...

Amended Statement of Beneficial Ownership (sc 13d/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 10...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on July 11, 2022 Registration Nos. 333-228384 333-230593...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on July 11, 2022 Registration Nos. 333-228384 333-230593...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on July 11, 2022 Registration Nos. 333-228384 333-230593...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on July 11, 2022 Registration Nos. 333-228384 333-230593...

Post-effective Amendment to Registration Statement (pos Am)

As filed with the Securities and Exchange Commission on July 11, 2022 Registration No. 333-258371 Registration No. 333-249315...

Post-effective Amendment to Registration Statement (pos Am)

As filed with the Securities and Exchange Commission on July 11, 2022 Registration No. 333-258371 Registration No. 333-249315...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Entasis Therapeutics

Intesa Sanpaolo

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales